Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP9X - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
EIF5B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
AK6 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
TXNDC9 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MTIF3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CELF1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PSMD12 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
FAM217B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SLC35E1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
ESF1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PLEKHA3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
STARD3NL - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MRPS31 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CCDC91 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CBX1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RIOK1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CXXC5 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
KCNJ2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on